Tia's high-engagement primary care model is driving strong clinical outcomes for women, consistently outperforming national benchmarks, the hybrid women's health provider reports.
The company published its 2025 outcomes in its annual Clinical Quality Report, now in its third iteration. The findings suggest that the more a patient engages with Tia, the better their outcomes are, executives said. Engagement was measured by utilization, retention and NPS score (above 90). New Tia patients were seen 10x in 2025, and patient retention was at over 80% year over year.
“Engagement is a key foundational factor,” Tia co-founder and CEO Felicity Yost told Fierce Healthcare in an exclusive interview. “That’s a really strong metric for us to be putting out there this year.”
Tia, a Fierce 15 of 2022 honoree, integrates primary care with gynecology, mental health and wellness service to provide a "modern medical home for women."
The company's annual report analyzed outcomes across preventive care, mental health, cardiometabolic health and quality of life, which consistently outperformed national benchmarks, the company claims. The average Tia patient is 34 years old, managing three chronic conditions and lives within 10 miles of a Tia clinic. Tia patients represent a wide span of household income, and 40% of Tia patients are non-white.
“We can do all the work we want to optimize the biomarker, but if a woman is still showing up feeling exhausted, depressed and not like herself in her body, then we’re not doing the things we need to do."— Felicity Yost
Tia’s goal is to get women to use core preventive care services that have a meaningful impact on long-term health outcomes. “If we could get women in their late 20s, early 30s, to start building a baseline of their health, how can we ultimately have better diagnostic pathways for them?” Yost said.
At Tia, the report found, 81% of patients got their cervical cancer screenings, compared to a 36% national average identified by the company. These screenings significantly reduce the risk of late-stage cervical cancer diagnoses, per the report. Nearly 9 in 10 got their depression screening, compared to 49% nationally. Similar to cervical cancer, this high screening rate helps identify “silent” depression early, per the report. Nearly half of Tia patients had chlamydia screenings, compared to 36% nationally, and 44% had HIV screenings compared to 18% nationally.
Nearly 7 in 10 high-risk diabetic patients got their A1c levels under control, compared to about 54% nationally. Average A1c levels dropped 3.3 points to the recommended level of below 8. While Tia does prescribe GLP-1s, it believes in a high-touch approach, meeting frequently with a patient throughout the year. If they’re on a new medication, they need monitoring to titrate effectively: “Putting a patient on a new medication and also finding the right baseline for that medication takes a lot of focus and feedback from the patient,” Yost noted. Tia generally sees diabetics every three months. Patients on new medications might be seen every six weeks.
Over the past year, Tia deployed several new programs to improve glycemic control. It established a partnership with Nourish, a virtual nutrition provider, to support Tia members with diet management and coaching. This is particularly important to safely manage patients on GLP-1s who are at risk for muscle loss and bone density concerns. Tia also established a support group for diabetes patients, overseen by a licensed administrator, to create a space for women to share and bond over life experiences and challenges.
New to this year’s report is the addition of a quality of life measure. Biomarkers alone don’t fully capture how women participate in their daily lives, Yost explained. Feeling in control is itself a health outcome, and improves adherence to care, per Yost. Average quality of life scores improved nearly nine points over 12 months. This is nearly double what is considered meaningful clinical change, according to Yost. A fifth of Tia patients received a “thriving,” exceeding national norms, the company claims.
“We can do all the work we want to optimize the biomarker, but if a woman is still showing up feeling exhausted, depressed and not like herself in her body, then we’re not doing the things we need to do,” Yost said.
While it’s too soon to report longevity outcomes, by EOY 2026 Tia expects to correlate quality of life improvement with measurable gains in cardiometabolic risk scores; blood pressure control; lipid panels; metabolic flexibility; and hormonal balance markers.
When it comes to mental health, more than a fifth of patients screened positive for moderate to severe depression. Two-thirds had at least one other clinical risk factor. Ultimately, 80% of those with high depression scores were bridged to specialized care, either through Tia’s internal psychiatric program or its integrated talk therapy partnerships like with Talkspace.
Nearly a third of patients with high depression scores achieved a 50% reduction in symptoms based on 2025 data. One in 5 reached remission. While most of these figures are in line with national standards, per Yost, what stood out was how quickly they were achieved. Nearly three-quarters of patients achieving clinical response did so within 180 days. More than half of patients reaching full remission did so within 180 days. That can typically take between one to two years, per Yost.
Tia works with health systems in every market, integrating with their EHRs, to make streamlined high-acuity care referrals. Patients can be fast-tracked into care, an important consideration for specialty care needs. “That enables us to manage the patient from a primary care lens in our setting, knowing what’s happening in that specialists’ setting, which is really different,” Yost said. The partners also help Tia build out its own offerings. CommonSpirit Health encouraged Tia to offer dermatology services, weighing in on their clinical guidelines, to avoid unnecessary referrals. Cedars-Sinai helped Tia develop cardiometabolic guidelines for managing women’s baseline cardiac risk.
Tia data indicate that more than 90% of its target population does not have a relationship with the primary health system in their market, Yost said. Over 70% do not have an established primary care doc, and more than 80% don’t have an established gynecologist. “We’re just continuing to see this trend of women who are really falling out of the traditional healthcare ecosystem,” Yost said. She referred to these patients as “medical orphans” until they come to Tia, adding, “At some point, these conditions need to be managed through a traditional primary care lens.”
Tia’s goal is to build a care model women actually want to use, integrating primary care with gynecology, mental health and wellness services. It operates 11 sites today, serving 75,000 women across those clinics. About half of its care is delivered in-person and half is online. “Virtual care is a huge extender for women. The majority of our patients are busy working women … the virtual option gives them more flexibility,” Yost said. Tia works with most major commercial payers in every market it’s in.
Editor's Note: An earlier version of this story mistakenly stated that Tia works with EHR companies. It integrates with the EHRs of its health system partners.